271 related articles for article (PubMed ID: 34014550)
1. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
Wang J; Huang R; Huang Y; Chen Y; Chen F
Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of
Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
Front Genet; 2022; 13():959832. PubMed ID: 36299588
[No Abstract] [Full Text] [Related]
3. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
5. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
6. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
Front Immunol; 2022; 13():892750. PubMed ID: 35812416
[TBL] [Abstract][Full Text] [Related]
7. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
Zeng Z; Cao Z; Zhang E; Huang H; Tang Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796
[TBL] [Abstract][Full Text] [Related]
8. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
9. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
10. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
11. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
13. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
Front Oncol; 2021; 11():665192. PubMed ID: 34123827
[TBL] [Abstract][Full Text] [Related]
14. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
15. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
16.
Zhang W; Liu Z; Xia S; Yao L; Li L; Gan Z; Tang H; Guo Q; Yan X; Sun Z
Aging (Albany NY); 2021 Dec; 13(23):25304-25324. PubMed ID: 34894398
[TBL] [Abstract][Full Text] [Related]
17. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
19. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Cai J; Zhou M; Xu J
World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Chen T; Zhu C; Wang X; Pan Y
Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
